Operator-adjusted disc-definition is successful method of glaucoma detection

Article

A recent study featured in the Journal of Glaucoma claims that operator-adjusted disc-definition is ideal for glaucoma detection when using the RTVue-100 Fourier-domain optical coherence tomograph

A recent study featured in the Journal of Glaucoma claims that operator-adjusted disc-definition is ideal for glaucoma detection when using the RTVue-100 Fourier-domain optical coherence tomograph.

An investigation led by Professor Gábor Holló et al., Semmelweis University, Hungary, evaluated the repeatability and between-method differences of optic nerve head, retinal nerve fibre layer thickness (RNFLT) measurements with the RTVue-100 Fourier-domain OCT.

All 3 disc-definition functions were used on one eye of each 126 patients. This included 72 glaucomatous, 10 ocular hypertensive and 44 healthy control eyes. To calculate measurement repeatability 33 eyes were imaged 5 times.

The findings suggested that automatic disc-definition was significantly poorer than other methods. Repeatability was matched between manual and operator-adjusted methods in all but one parameter. Refractive error, disease category or peripapillary atrophy had no effect on repeatability. Parameters measured with manual and operator-adjusted methods demonstrated high intraclass correlation (93.5% to 99.9%).

Manual and operator-adjusted disc-definition functions have similar measurement repeatability and are not influenced by refractive error, glaucoma or parapapillary atrophy. It was reported that the RTVue-100 Fourier-domain OCT method is effective in the detection of glaucoma and has high intraclass correlation.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.